Documents & Downloads

rel-(E)-BMY 21950 sodium

Relative Configuration of BMY 21950

rel-(E)-BMY 21950 sodium is designed to provide the relative configuration of BMY 21950, a potent inhibitor of HMG-CoA reductase. By inhibiting this enzyme, BMY 21950 effectively reduces hepatic cholesterol synthesis. This reagent is valuable for research applications focused on cholesterol metabolism and cardiovascular disease.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	130200-44-1
Applications	Relative Configuration of BMY 21950
Formula	C₂₃H₂₁F₂N₄NaO₄
Molecular Weight	478.42
SMILES	FC(C=C1)=CC=C1/C(C2=CC=C(F)C=C2)=C(C3=NN=NN3C)\C=C\[C@@H](O)C[C@@H](O)CC(O[Na])=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.